ArticleCancer research and treatment2019

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin.

Jaewon Hyung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.